NASDAQ: POCIPrecision Optics Corporation Inc Stock
$5.26-0.15 (-2.77%)
Updated Jun 23, 2026
POCI Price
$5.26
Fair Value Price
N/A
Market Cap
$57.57M
52 Week Low
$3.55
52 Week High
$6.15
P/E
-8.35x
P/B
2.86x
P/S
1.18x
PEG
N/A
Dividend Yield
N/A
Revenue
$28.94M
Earnings
-$4.93M
Gross Margin
13.8%
Operating Margin
-16.44%
Profit Margin
-17%
Debt to Equity
0.68
Operating Cash Flow
-$1M
Beta
0.16
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
POCI Overview
Precision Optics Corporation, Inc. (POCI) specializes in the engineering, manufacturing, and sale of advanced optical and illumination systems, along with their complementary components. Its main operational regions are the United States and the European Economic Area. The company's offerings include medical instruments such as various types of endoscopes and endocouplers. Moreover, POCI provides bespoke imaging and lighting solutions, encompassing high-precision Microprecision lenses, miniature medical cameras, and cutting-edge 3D endoscopes, all designed for application in minimally invasive surgical procedures carried out by hospitals and healthcare professionals. Beyond its medical division, POCI also produces individual parts and integrated assemblies for industrial and military purposes. POCI markets its medical device portfolio primarily to other corporations within the medical technology sector. Established in 1982, the firm's headquarters are located in Gardner, Massachusetts.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine POCI's potential to beat the market
- POCI doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical
Industry Rating
A
POCI
RankedUnranked of 40
RankedUnranked of 40
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $9.08 | A | |
| $15.24 | B | |
| $21.75 | B |
Be the first to know about important POCI news, forecast changes, insider trades & much more!
POCI News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how POCI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
POCI is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
POCI is good value based on its book value relative to its share price (2.86x), compared to the US Medical Instruments & Supplies industry average (3.14x)
P/B vs Industry Valuation
POCI is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more POCI due diligence checks available for Premium users.
Valuation
POCI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-8.35x
Industry
41.95x
Market
7.68x
POCI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.86x
Industry
3.14x
POCI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
POCI's financial health
Profit margin
Revenue
$8.7M
Net Income
-$108.3k
Profit Margin
-1.2%
POCI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
POCI's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$33.7M
Liabilities
$13.6M
Debt to equity
0.68
POCI's short-term assets ($21.41M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
POCI's short-term assets ($21.41M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
POCI's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
POCI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$723.3k
Investing
$49.5k
Financing
$10.5M
POCI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
POCI vs Medical Stocks
Precision Optics Corporation Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.